<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02292576</url>
  </required_header>
  <id_info>
    <org_study_id>11.21.NRC</org_study_id>
    <nct_id>NCT02292576</nct_id>
  </id_info>
  <brief_title>Genetic and Epigenetic Mechanisms Underlying Cocoa Health Benefits</brief_title>
  <official_title>Genetic and Epigenetic Mechanisms Underlying Cocoa Health Benefits</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate if gene expression changes in SOD2 explain the health benefits of high polyphenols
      cocoa
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluate if gene expression changes in SOD2 explain the health benefits of high polyphenols
      cocoa.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of changes in SOD2 gene expression</measure>
    <time_frame>after acute dose and 4 weeks of chronic dose</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determination of DNA methylation pattern in the chronic phase of the study</measure>
    <time_frame>After 4 weeks of chronic dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of (-)epicatechin bioavailability in plasma</measure>
    <time_frame>After 4 weeks of chronic dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of plasma antioxidant capacity as a marker of oxidative stress</measure>
    <time_frame>After 4 weeks of chronic dose</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Acute dose/Chronic dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acute dose/Chronic dose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic dose/Acute dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Chronic dose/Acute dose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cocoa Pure</intervention_name>
    <description>Cocoa Pure.</description>
    <arm_group_label>Acute dose/Chronic dose</arm_group_label>
    <arm_group_label>Chronic dose/Acute dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo.</description>
    <arm_group_label>Acute dose/Chronic dose</arm_group_label>
    <arm_group_label>Chronic dose/Acute dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adults

          -  BMI between 18.5 and 30 kg/m2

          -  Sedentary to moderate physical activity habits

        Exclusion Criteria:

          -  Consumption of dietary supplements, antioxidants or anti-inflammatory medication, such
             as aspirin, ibuprofen, naproxen, or any medication that can affect the study outcomes

          -  Actively smoking

          -  Suspected abuse of alcohol or illicit drugs

          -  Significant illness within two weeks prior to study start or any active systemic
             infection or medical condition that may require treatment or therapeutic intervention
             during the study

          -  Subject who cannot be expected to comply with study procedures

          -  Currently participating or having participated in another clinical trial during last 4
             weeks prior to the beginning of this study

          -  Consumption of chocolate or its derivates 24 hours before the blood sample taken
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Elizabeth Tejero Barrera, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Nacional de Medicina Genomica</affiliation>
  </overall_official>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2014</study_first_submitted>
  <study_first_submitted_qc>November 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2014</study_first_posted>
  <last_update_submitted>November 14, 2014</last_update_submitted>
  <last_update_submitted_qc>November 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>volunteers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

